We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$54.7B
AUM Growth
+$1.45B
(+2.7%)
Cap. Flow
+$1.02B
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$65.3M |
| 2 |
Global Payments
GPN
|
+$40.3M |
| 3 |
Microsoft
MSFT
|
+$37.9M |
| 4 |
L3Harris
LHX
|
+$32.8M |
| 5 |
Amazon
AMZN
|
+$32.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$64.3M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$57.1M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$40M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$39.2M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.64% |
| 2 | Financials | 15.56% |
| 3 | Healthcare | 12.85% |
| 4 | Consumer Discretionary | 10.31% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Rocket Pharmaceuticals
RCKT
$382M
| $429K | ﹤0.01% |
36,823
-140
| -0.4% | -$1.74K |
|
|
BBBY
2402
Bed Bath & Beyond
BBBY
$440M
| $428K | ﹤0.01% |
53,834
+5,142
| +11% | +$70.3K |
|
2403
Rigel Pharmaceuticals
RIGL
$756M
| $428K | ﹤0.01% |
22,905
+59
| +0.3% | +$1.22K |
|
2404
Atlanta Braves Holdings Series A
BATRA
$3.39B
| $425K | ﹤0.01% |
15,281
-40
| -0.3% | -$1.13K |
|
2405
NVE Corp
NVEC
$613M
| $425K | ﹤0.01% |
6,401
-5
| -0.1% | -$341 |
|
2406
The RealReal
REAL
$1.52B
| $425K | ﹤0.01% |
+19,007
| New | +$382K |
|
2407
Western New England Bancorp
WNEB
$281M
| $425K | ﹤0.01% |
44,585
+3,097
| +7% | +$28.4K |
|
2408
Green Brick Partners
GRBK
$3.15B
| $424K | ﹤0.01% |
39,638
+3,374
| +9% | +$32.4K |
|
2409
NWPX Infrastructure Inc
NWPX
$1.2B
| $424K | ﹤0.01% |
15,066
+1,396
| +10% | +$35.5K |
|
2410
MediciNova
MNOV
$65.5M
| $419K | ﹤0.01% |
52,714
-400
| -0.8% | -$3.57K |
|
2411
National Bankshares
NKSH
$262M
| $418K | ﹤0.01% |
10,438
+803
| +8% | +$29.1K |
|
2412
Limoneira
LMNR
$249M
| $416K | ﹤0.01% |
22,678
+2,104
| +10% | +$40.1K |
|
2413
Bridgewater Bancshares
BWB
$588M
| $415K | ﹤0.01% |
34,798
+3,098
| +10% | +$35.9K |
|
2414
Greif Class B
GEF.B
$4.23B
| $414K | ﹤0.01% |
9,094
+851
| +10% | +$36.6K |
|
|
PRNB
2415
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $411K | ﹤0.01% |
14,544
+290
| +2% | +$10.6K |
|
|
CVRS
2416
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $411K | ﹤0.01% |
96,097
+5,265
| +6% | +$19.1K |
|
2417
Calix
CALX
$2.42B
| $410K | ﹤0.01% |
64,171
+3,119
| +5% | +$19.7K |
|
2418
Metropolitan Bank Holding Corp
MCB
$1.17B
| $410K | ﹤0.01% |
10,435
+921
| +10% | +$37.2K |
|
2419
Northrim BanCorp
NRIM
$600M
| $408K | ﹤0.01% |
41,160
+3,224
| +8% | +$30K |
|
|
KDMN
2420
DELISTED
Kadmon Holdings, Inc.
KDMN
| $407K | ﹤0.01% |
161,455
-1,300
| -0.8% | -$3.23K |
|
2421
Arvinas
ARVN
$542M
| $405K | ﹤0.01% |
18,791
+380
| +2% | +$9.32K |
|
2422
Farmers & Merchants Bancorp
FMAO
$470M
| $405K | ﹤0.01% |
15,603
+1,361
| +10% | +$36.3K |
|
|
BSTC
2423
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $405K | ﹤0.01% |
7,575
-75
| -1% | -$4.37K |
|
|
SYRS
2424
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $404K | ﹤0.01% |
3,893
-27
| -0.7% | -$2.55K |
|
2425
Blue Bird Corp
BLBD
$2.43B
| $401K | ﹤0.01% |
21,058
+1,066
| +5% | +$20.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2019 Portfolio in Review
As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
- RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
- RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
- RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
- RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.
Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.